Valneva announces successful outcome of its agm and the appointment of pfizer's former vaccine r&d head to its supervisory board

Saint - herblain ( france), june 2 1 , 202 3 – valneva s e (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that all the resolutions recommended by the management board were approved by the shareholders at its annual general meeting (agm) held today in lyon, france.
VALN Ratings Summary
VALN Quant Ranking